This inventor holds 1 USPTO granted patent. Top assignee: Infex Therapeutics Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: James Kirkham: Innovator in Antibacterial Treatments
Introduction
James Kirkham is a notable inventor based in Cheshire, GB. He has made significant contributions to the field of antibacterial treatments through his innovative research and development. His work focuses on creating compounds that can effectively combat bacterial infections.
Latest Patents
James Kirkham holds a patent for "1-aminosulfonyl-2-carboxypyrrole derivatives as metallo-beta-lactamase inhibitors." This invention relates to compounds of formula (I) and methods of treatment using these compounds. The compounds can be used in combination with antibacterial agents to treat bacterial infections. More specifically, they can be used alongside a class of antibacterial agents known as carbapenems. The novel compounds are enzyme inhibitors, particularly metallo-β-lactamase inhibitors.
Career Highlights
James Kirkham is associated with Infex Therapeutics Limited, where he continues to advance his research in antibacterial treatments. His work has the potential to significantly impact the medical field by providing new solutions to combat antibiotic resistance.
Collaborations
James collaborates with talented individuals such as Adam Bunt and Fredrik Wångsell, who contribute to the innovative environment at Infex Therapeutics Limited.
Conclusion
James Kirkham's contributions to antibacterial treatments through his patented inventions highlight his role as a key innovator in the field. His work is essential in the ongoing battle against bacterial infections and antibiotic resistance.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile